Literature DB >> 19481544

The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription.

Hee-Bum Kang1, Youngsok Choi, Jae Myun Lee, Kyung-Chul Choi, Han-Cheon Kim, Jung-Yoon Yoo, Yoo-Hyun Lee, Ho-Geun Yoon.   

Abstract

In this study, we discovered that NSD2 specifically interacts with the DNA-binding domain of androgen receptor (AR) via its HMG domain, and the nuclear translocation of both NSD2 and AR is enhanced in the presence of ligand. Furthermore, we also demonstrated that the over expression of NSD2, but not of NSD2 (DeltaSET) HMT-activity defective mutant, enhanced the mRNA level of PSA in a dose-dependent manner. A chromatin immunoprecipitation assay showed that NSD2 protein is recruited to the enhancer region of the PSA gene by AR in an agonist-enhanced manner. Taken together, these results uncover a potential role for NSD2 in AR-mediated transcription, implicating NSD2 in prostate carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481544     DOI: 10.1016/j.febslet.2009.05.038

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.

Authors:  Qi Qiao; Yan Li; Zhi Chen; Mingzhu Wang; Danny Reinberg; Rui-Ming Xu
Journal:  J Biol Chem       Date:  2010-12-31       Impact factor: 5.157

2.  An open and shut case for the role of NSD proteins as oncogenes.

Authors:  Agda Karina Lucio-Eterovic; Phillip B Carpenter
Journal:  Transcription       Date:  2011-07

Review 3.  H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.

Authors:  David S Rogawski; Jolanta Grembecka; Tomasz Cierpicki
Journal:  Future Med Chem       Date:  2016-08-22       Impact factor: 3.808

4.  MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib.

Authors:  Z Xie; C Bi; J Y Chooi; Z L Chan; N Mustafa; W J Chng
Journal:  Leukemia       Date:  2015-06-30       Impact factor: 11.528

Review 5.  Histone methyltransferases: regulation of transcription and contribution to human disease.

Authors:  Keisuke Nimura; Kiyoe Ura; Yasufumi Kaneda
Journal:  J Mol Med (Berl)       Date:  2010-08-17       Impact factor: 4.599

6.  Epigenetic Coregulation of Androgen Receptor Signaling.

Authors:  Rayzel C Fernandes; Damien A Leach; Charlotte L Bevan
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 7.  The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.

Authors:  Iuliia Topchu; Rajendra P Pangeni; Igor Bychkov; Sven A Miller; Evgeny Izumchenko; Jindan Yu; Erica Golemis; John Karanicolas; Yanis Boumber
Journal:  Cell Mol Life Sci       Date:  2022-05-09       Impact factor: 9.207

8.  Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma.

Authors:  Peng Zhou; Lie-Lin Wu; Ke-Min Wu; Wei Jiang; Jin-Dong Li; Le-du Zhou; Xin-Ying Li; Shi Chang; Yun Huang; Hui Tan; Ge-Wen Zhang; Feng He; Zhi-Ming Wang
Journal:  Pathol Oncol Res       Date:  2012-12-08       Impact factor: 3.201

Review 9.  Histone H1 Mutations in Lymphoma: A Link(er) between Chromatin Organization, Developmental Reprogramming, and Cancer.

Authors:  Alexey A Soshnev; C David Allis; Ethel Cesarman; Ari M Melnick
Journal:  Cancer Res       Date:  2021-09-27       Impact factor: 13.312

Review 10.  Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Authors:  Mariana Brütt Pacheco; Vânia Camilo; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2021-06-15       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.